Lessons from the European Cooperative recombinant tissue-type plasminogen activator (rt-PA) versus placebo trial
- 31 December 1988
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 12 (6), A14-A19
- https://doi.org/10.1016/0735-1097(88)92636-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- THROMBOLYSIS AFTER MYOCARDIAL INFARCTIONThe Lancet, 1988
- The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.Circulation, 1988
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Effects of early high-dose streptokinase intravenously on left ventricular function in acute myocardial infarctionThe American Journal of Cardiology, 1987
- A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): Long-term mortality and morbidityJournal of the American College of Cardiology, 1987
- Coronary thrombolysis with recombinant tissue-type plasminogen activator: Patency rate and regional wall motion after 3 monthsJournal of the American College of Cardiology, 1986
- A randomized controlled trial of intravenous streptokinase in evolving acute myocardial infarctionAmerican Heart Journal, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985